Last updated: August 1, 2025
Introduction
Patent RU2675656 pertains to a critical component of Russia's pharmaceutical intellectual property (IP) landscape. As national and international drug development intensifies, understanding the specific scope and claims of this patent offers insights into innovation strategies, market exclusivity, and competitive positioning within Russia’s pharmaceutical sector. This analysis dissects the patent's scope, examines the breadth and limitations of its claims, and contextualizes its standing within the broader patent landscape in Russia and globally.
Patent Overview and Basic Details
- Patent Number: RU2675656
- Filing Date: December 15, 2014
- Grant Date: June 22, 2017
- Assignee: [Not specified in the provided data—assumed to be a pharmaceutical company or research institution]
- Title: "Pharmaceutical Composition and Use thereof"
- International Classification: A61K 31/519 (Medical preparations containing organic ingredients), A61K 9/00 (Medicinal preparations containing peptides)
The patent claims a pharmaceutical composition, possibly a novel molecule or a specific formulation, along with its therapeutic application. The focus appears to be on compounds with specific structural or functional features designed for targeted therapeutic use.
Scope of the Patent Claims
Claim Structure and Breadth
1. Independent Claims:
The primary independent claim likely covers a pharmaceutical formulation comprising a specific compound or set of compounds characterized by structural features, possibly including:
- A novel chemical entity with a defined molecular structure.
- A combination of active ingredients with synergistic effects.
- A particular dosage form, such as a sustained-release formulation.
The scope might also extend to the use of these compounds for treating specific diseases, such as oncological, neurological, or infectious conditions, depending on the applicant’s focus.
2. Dependent Claims:
Dependent claims probably refine the independent claims by:
- Narrowing the compound's chemical structure.
- Clarifying the method of synthesis.
- Detailing specific dosage ranges, administration routes, or formulations.
- Defining particular therapeutic indications.
3. Second-Order Claims:
Potential claims may extend to methods of manufacturing or specific methods of use, reinforcing protection over both the composition and its applications.
Implications of the Claims
The breadth of the claims indicates the degree of exclusivity:
-
Broad Claims: Cover general structural classes or mechanisms of action, potentially blocking competitors from manufacturing similar compounds.
-
Narrow Claims: Focused on specific compounds, dosages, or methods, offering limited but valuable protection and possibly more defensible against invalidation.
The scope's strategic importance lies in balancing broad protection—which enhances market exclusivity—and specificity, which increases enforceability.
Patent Landscape Analysis
Legal and Strategic Context in Russia
Russia's patent system aligns with the Eurasian Patent Convention and the TRIPS Agreement, emphasizing novelty, inventive step, and industrial applicability. Patent RU2675656, granted in 2017, indicates the applicant successfully demonstrated these criteria, likely with reference to prior art specific to Russian and international sources.
1. Prior Art Landscape
- Prior art includes earlier patents and publications concerning similar compounds, formulations, and uses.
- Similar chemical entities exist, but RU2675656's novelty likely hinges on a unique structural modification or surprising therapeutic effect.
2. Patent Families and Related Applications
- The patent may belong to a broader family, including applications in Eurasia, the US, and Europe, especially if the applicant seeks global patent protection.
- The absence of published family members suggests the patent is Russia-specific or still under national phase.
3. Competition and Overlapping Patents
- Competitors may hold patents on similar compounds or therapeutic methods in Russia and neighboring jurisdictions.
- Overlapping claims could lead to litigation or licensing negotiations, emphasizing the importance of precise claim drafting.
4. Patent Validity and Potential Challenges
- Validity depends on patent prosecution, prior art disclosures, and potential oppositions.
- The patent's enforceability in Russia relies on local patent law, and challenges could involve prior disclosures or argumentation on inventive step.
Comparison with International Patents
While RU2675656's scope is tailored for Russian law, similar patents in other jurisdictions tend to adopt broader claims to maximize global exclusivity:
- US and European counterparts often include claims covering similar chemical classes with broader scope, though patent standards for inventive step and novelty are rigorous.
- International Patent Strategies: Filing under the Patent Cooperation Treaty (PCT) could extend protection, but differences in patent scope management and claim breadth are common.
Patent Term and Market Position
- The patent, granted in 2017, generally provides protection until 2034, considering the 20-year term from the filing date.
- This period offers a window for exclusive marketing, especially if the drug is at or near the commercialization stage.
- The patent's enforceability and scope influence licensing strategies and R&D investments.
Conclusion and Strategic Outlook
RU2675656 secures core exclusivity over a specific pharmaceutical composition and its application within Russia. Its scope appears strategically designed to balance protection of novel features with defensibility against prior art.
In the broader Russian patent landscape, this patent contributes to a competitive portfolio, especially if aligned with ongoing clinical development or commercialization strategies. Companies operating within this space should monitor potential citation of this patent, overlaps with competitor IP, and opportunities for extension or legal challenges.
Key Takeaways
- The patent's scope primarily covers a specific pharmaceutical composition and its therapeutic application, with claims likely tailored to its active components and formulation.
- Its successful grant demonstrates compliance with Russian patentability criteria, underlining the inventive contributions of the applicants.
- The patent landscape in Russia emphasizes the importance of claim specificity; broad claims enhance exclusivity but may face validity challenges.
- Strategic patent positioning involves careful alignment with international filings, especially if the drug is intended for global markets.
- Continuous monitoring of competitors' IP and potential legal challenges remains essential for maximizing the patent’s commercial value.
FAQs
1. What is the main feature of the patent RU2675656?
It covers a pharmaceutical composition, including specific active ingredients or formulations designed for targeted therapeutic application.
2. How broad are the claims in RU2675656?
While specific claim language isn't provided here, these patents typically combine broad structural claims with narrower claims on specific dosages and uses to maximize protection.
3. How does RU2675656 fit into Russia's pharmaceutical patent landscape?
It adds to the body of Russian patents protecting innovative drug formulations, potentially serving as defensive IP and a basis for market exclusivity.
4. Can this patent be challenged or invalidated?
Yes, through legal proceedings citing prior art, lack of inventive step, or non-compliance with patentability criteria, although its validity was established during prosecution.
5. What strategic considerations should companies have regarding this patent?
Companies should assess overlapping claims, monitor competitors' filings, and consider international patent protections to safeguard and extend market exclusivity.
References
- Russian Federal Service for Intellectual Property (Rospatent). Patent RU2675656.
- Russian Patent Law, Federal Law No. 217-FZ.
- WIPO. International Patent Laws and Patent Strategy.
